Literature DB >> 1522211

Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus.

E C De Mendonca Neto1, A Kumar, N A Shadick, A M Michon, P Matsudaira, R B Eaton, P Kumar, P H Schur.   

Abstract

The cytoskeleton is a complex network of proteins that maintain cell shape, mobility, and organelle function. Its components can be divided into three distinct classes: microfilaments, microtubules, and intermediate filaments. Fimbrins are microfilament proteins, a family of cytoplasmic phosphoproteins. Expression of the L-fimbrin isoform is restricted to replicating blood cells and expression of the T-fimbrin isoform to replicating cells of solid tissues. Sera from normals and from patients with systemic lupus erythematosus (SLE), juvenile arthritis, rheumatoid arthritis, Sjögren's syndrome, osteoarthritis, vasculitis, scleroderma, and mixed connective tissue disease were tested for the presence of antibodies to T- and L-fimbrin by ELISA, using purified recombinant fimbrin. The mean OD of sera from SLE patients was significantly higher than in normals (T-fimbrin, P less than 0.0001; L-fimbrin, P less than 0.001). 48 of 98 SLE sera had antibodies to T-fimbrin; 32 had antibodies to L-fimbrin; 20 had antibodies to both; 28 had only anti-T, and 12 had only anti-L-fimbrin. The mean OD for sera of the other rheumatic diseases was not significantly different from normals. The presence of either L- or T-fimbrin antibody was associated with pleuropericarditis (P = 0.015), photosensitivity (P = 0.011), and anti-Sm antibody (P = 0.010). Central nervous system SLE was associated with the presence of the L-fimbrin antibody alone (P = 0.016). There was a strong association between DR7 (but not other MHC alleles) and anti-L-fimbrin antibodies in SLE patients (chi square = 18; P less than 0.00002). No MHC association was observed with anti-T-fimbrin antibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522211      PMCID: PMC329961          DOI: 10.1172/JCI115917

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  The relationship between Sm and RNP antigens.

Authors:  Z Fronek; R R Valle; R B Eaton; P H Schur
Journal:  Clin Immunol Immunopathol       Date:  1986-10

2.  Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis.

Authors:  K Lidman; G Biberfeld; A Fagraeus; R Norberg; R Torstensson; G Utter; L Carlsson; J Luca; U Lindberg
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

Review 3.  Actin and actin-binding proteins. A critical evaluation of mechanisms and functions.

Authors:  T D Pollard; J A Cooper
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

4.  Intermediate filament associated proteins.

Authors:  E Wang
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

5.  The molecules of the cell matrix.

Authors:  K Weber; M Osborn
Journal:  Sci Am       Date:  1985-10       Impact factor: 2.142

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 7.  Subsets in systemic lupus erythematosus.

Authors:  T T Provost
Journal:  J Invest Dermatol       Date:  1979-03       Impact factor: 8.551

8.  Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans.

Authors:  P F Howard; M C Hochberg; W B Bias; F C Arnett; R H McLean
Journal:  Am J Med       Date:  1986-08       Impact factor: 4.965

9.  Hybridoma lupus autoantibodies can bind major cytoskeletal filaments in the absence of DNA-binding activity.

Authors:  J L Senécal; J Rauch
Journal:  Arthritis Rheum       Date:  1988-07

10.  Fimbrin is a homologue of the cytoplasmic phosphoprotein plastin and has domains homologous with calmodulin and actin gelation proteins.

Authors:  M V de Arruda; S Watson; C S Lin; J Leavitt; P Matsudaira
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

View more
  1 in total

1.  Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss.

Authors:  Xiaoqun Li; Lipeng Wang; Biaotong Huang; Yanqiu Gu; Ying Luo; Xin Zhi; Yan Hu; Hao Zhang; Zhengrong Gu; Jin Cui; Liehu Cao; Jiawei Guo; Yajun Wang; Qirong Zhou; Hao Jiang; Chao Fang; Weizong Weng; Xiaofei Chen; Xiao Chen; Jiacan Su
Journal:  Sci Adv       Date:  2020-11-18       Impact factor: 14.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.